Document Detail


Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharide-induced acute inflammation.
MedLine Citation:
PMID:  20118807     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Intestinal permeability and barrier function are regulated by expression of tight junction proteins. Lipopolysaccharide (LPS), tumor necrosis factor-alpha, and interleukin-1beta induce expression of nitric oxide (NO) and reduce the expression of gut tight junction proteins. The purpose of this study was to determine whether dietary gangliosides (GGs) increase the concentration of the anti-inflammatory cytokine interleukin-10 (IL-10) in response to LPS, thereby inhibiting NO production and protecting gut occludin tight junction protein from degradation. MATERIALS AND METHODS: Rats were fed semipurified diets with (n = 16) or without (n = 16) GGs (0.1% w/w of total lipid). After 2 weeks of feeding, animals were injected with saline (n = 8/diet group) or LPS (n = 8/diet group) (IP, 3 mg mL(-1) kg(-1)). Intestinal tissue, mucosa, and blood sample were collected 6 hours post-LPS exposure. The effect of dietary GGs on production/expression of IL-10, NO, inducible NO synthase, and occludin protein was determined. RESULTS: Dietary GGs increased IL-10 content in intestinal mucosa significantly by 32-fold (P < 0.0001) and in plasma by 2.4-fold (P < 0.001). Feeding animals a ganglioside-enriched diet decreased total NO content in intestinal mucosa and plasma by 44% and 30%, respectively, and inhibited inducible NO synthase expression following LPS exposure compared with control animals. Dietary GGs reduced the degradation of occludin tight junction protein in response to LPS. CONCLUSIONS: Dietary GGs inhibit degradation of gut occludin tight junction protein during LPS-induced acute inflammation. Thus, dietary GGs have a role in protecting the integrity of the intestinal barrier during acute gut inflammation.
Authors:
Eek J Park; Alan B R Thomson; Michael T Clandinin
Related Documents :
17435027 - Gastrointestinal maturation is accelerated in turkey poults supplemented with a mannan-...
14730317 - Assessing the survival of transgenic plant dna in the human gastrointestinal tract.
13978797 - The absorption of fat by intestine of golden hamster in vitro.
908407 - Morphological appearance of fat in the epithelial cells of different portions of the in...
18644687 - Effect of dietary supplements of mussel and polychaetes on spawning performance of capt...
16081267 - Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of pediatric gastroenterology and nutrition     Volume:  50     ISSN:  1536-4801     ISO Abbreviation:  J. Pediatr. Gastroenterol. Nutr.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-01     Completed Date:  2010-08-17     Revised Date:  2010-11-02    
Medline Journal Info:
Nlm Unique ID:  8211545     Medline TA:  J Pediatr Gastroenterol Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  321-8     Citation Subset:  IM    
Affiliation:
Alberta Institute for Human Nutrition, Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Animals
Anti-Inflammatory Agents / pharmacology*
Cell Membrane Permeability / drug effects
Dietary Fats / administration & dosage*
Gangliosides / pharmacology*
Inflammation / chemically induced,  drug therapy*,  metabolism
Interleukin-10 / blood,  metabolism
Intestinal Absorption
Intestinal Mucosa / drug effects*,  metabolism
Lipopolysaccharides
Male
Membrane Proteins / metabolism*
Nitric Oxide / blood,  metabolism
Nitric Oxide Synthase Type II / metabolism
Rats
Rats, Sprague-Dawley
Tight Junctions / drug effects*,  metabolism
Grant Support
ID/Acronym/Agency:
//Canadian Institutes of Health Research
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Dietary Fats; 0/Gangliosides; 0/Lipopolysaccharides; 0/Membrane Proteins; 0/occludin; 10102-43-9/Nitric Oxide; 130068-27-8/Interleukin-10; EC 1.14.13.39/Nitric Oxide Synthase Type II
Comments/Corrections
Erratum In:
J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):687

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Performance of the AST-to-Platelet Ratio Index as a Noninvasive Marker of Fibrosis in Pediatric Pati...
Next Document:  Fatty Acid Profile Comparisons in Human Milk Sampled From the Same Mothers at the Sixth Week and the...